Antiplatelet drug
From Free net encyclopedia
Revision as of 03:54, 4 March 2006; view current revision
←Older revision | Newer revision→
←Older revision | Newer revision→
An antiplatelet drug is a member of a class of pharmaceuticals that decreases platelet aggregation and inhibits thrombus formation. They are effective in the arterial circulation, where anticoagulants have little effect.
They are widely used in primary and secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
The most important antiplatelet drugs are :
- cyclooxygenase inhibitors
- adenosine diphosphate receptor inhibitors
- clopidogrel (Plavix)
- ticlopidine (Ticlid)
- phosphodiesterase inhibitors
- cilostazol (Pletal)
- glycoprotein IIB/IIIA inhibitors (intravenous use only)
- abciximab (ReoPro)
- eptifibatide (Integrilin)
- tirofiban (Aggrastat)
- adenosine reuptake inhibitors
- dipyridamole (Persantine)
[edit]